Simethicone containing pharmaceutical compositions

Details Simethicone containing pharmaceutical compositions Simethicone containing pharmaceutical compositions

1996-03-20

1998-02-10

Webman, Edward J.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Tablets, lozenges, or pills

424469, 424461, 424462, 424490, 424494, 424495, 424497, A61K 958, A61K 962, A61K 924, A61K 926

Patent

active

057166412

ABSTRACT:
A solid oral dosage form for the treatment of gastrointestinal disorders comprising a therapeutically effective amount of a pharmaceutical suitable for the treatment of gastric disorders selected from the group consisting of cimetidine, ranitidine, famotidine, diphenoxylate, loperamide, loperamide-N-oxide, pharmaceutically acceptable salts thereof and combinations thereof; and a therapeutically effective amount of simethicone wherein the pharmaceutical and simethicone are separated by a barrier which is substantially impermeable to simethicone.

REFERENCES:
patent: 3767794 (1973-10-01), McVean et al.
patent: 4127650 (1978-11-01), Buchler
patent: 4198390 (1980-04-01), Rider
patent: 4316888 (1982-02-01), Nelson
patent: 4396604 (1983-08-01), Mitra
patent: 4639368 (1987-01-01), Niazi et al.
patent: 4857324 (1989-08-01), Mir et al.
patent: 5073384 (1991-12-01), Valentine et al.
patent: 5075114 (1991-12-01), Roche
patent: 5169640 (1992-12-01), France et al.
patent: 5204118 (1993-04-01), Goldman et al.
patent: 5229137 (1993-07-01), Wolfe
patent: 5248505 (1993-09-01), Garwin
patent: 5260072 (1993-11-01), Roche et al.
J. Alfred Rider, "An Improved Simethicone Antacid Tablet", pp. 1033-1038 (1981).
F. Maksoud, S.A. Said and M. Gourab, "Simethicone Use in Antacid Medications", pp. 35 and 36 (1976).
J.K. Lalla and M.A. Sarkar, "Preparation and Stability Testing of Simethicone Emulsion", pp. 159-166 (1985).
Cellulose Esters Polymer Characterization, Bulletin CE-2, FMC Corp. (1987).
Cellulose Esters Polymers for Novel Drug Delivery, Bulletin CE-1, FMC Corp. (1986).
CA115(24):263465f, Pharmaceutical Composition for Treating Gastrointestional Distress (1991).
CA111(2):12462a, Incorporation of Simethicone into Syrupy or Clear Base Liquid Orals (1989).
CA97(13): 103890x, The Effect of Activated Dimethicone and a Proprietary Antacid Preparation Containingthis Agent on the absorption of Phenytoin (1982).
CA96(25):210465p, The Effect of Activated Dimethicone, Other Antacid Constituents, and Kaolin on the Absorption of Propranolol (1982).
CA93(14):138018p, Uniform Beadlike Particles Forming a Powder Surpuriya (1980).
CA90(17):132533u, Interaction of Digoxin with Activated Dimethicone and Other Antacid Constituents (1979).
CA107(4):28386g, Drugs in Combined Gastro-Soluble and Gastro-Resistant Form (1986).
C71-S36634, Flatulence Treatment with Antifoaming -Comn (1974).
C75-W80496, Medicaments for Treating Nervous Hyperacidity, Etc. --Contg. a Psychsedative, and Antacid, and an Antiflatuent (1975).

Affiliated with

Also associated with

Rating

Simethicone containing pharmaceutical compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Simethicone containing pharmaceutical compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Simethicone containing pharmaceutical compositions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2075236